ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,000 | +200.0% | 75 | +158.6% | 0.00% | – |
| Q2 2020 | $2,000 | -100.0% | 29 | -100.0% | 0.00% | -100.0% |
| Q1 2020 | $4,989,000 | +0.4% | 118,792 | +8.5% | 0.02% | +36.4% |
| Q4 2019 | $4,971,000 | -2.3% | 109,452 | -1.5% | 0.01% | -15.4% |
| Q3 2019 | $5,086,000 | -43.4% | 111,118 | -27.5% | 0.01% | -40.9% |
| Q2 2019 | $8,986,000 | +113.6% | 153,269 | +63.4% | 0.02% | +120.0% |
| Q1 2019 | $4,206,000 | – | 93,812 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |